Algert Global’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-273,557
| Closed | -$323K | – | 1307 |
|
|
2025
Q1 | $323K | Hold |
273,557
| – | – | 0.01% | 994 |
|
|
2024
Q4 | $501K | Buy |
273,557
+22,361
| +9% | +$41K | 0.01% | 909 |
|
|
2024
Q3 | $427K | Sell |
251,196
-89,870
| -26% | -$153K | 0.01% | 931 |
|
|
2024
Q2 | $467K | Buy |
341,066
+161,066
| +89% | +$221K | 0.02% | 941 |
|
|
2024
Q1 | $675K | Buy |
180,000
+150,640
| +513% | +$565K | 0.03% | 710 |
|
|
2023
Q4 | $288K | Buy |
+29,360
| New | +$288K | 0.01% | 946 |
|
|
2022
Q3 | – | Sell |
-33,340
| Closed | -$147K | – | 1293 |
|
|
2022
Q2 | $147K | Buy |
+33,340
| New | +$147K | 0.01% | 1066 |
|
|
2021
Q4 | – | Sell |
-12,111
| Closed | -$309K | – | 1073 |
|
|
2021
Q3 | $309K | Buy |
12,111
+991
| +9% | +$25.3K | 0.04% | 750 |
|
|
2021
Q2 | $389K | Buy |
+11,120
| New | +$389K | 0.13% | 223 |
|